Invokana is Johnson & Johnson’s brand name for canagliflozin, a diabetes drug approved by the FDA in March 2013. Invokana is one of a category of medications used to treat type 2 diabetes and known as sodium-glucose costransporter-2, or SGLT2, inhibitors. Recently, there have been ongoing FDA warnings and reports of adverse effects of Invokana and other SGLT2 inhibitors.
Recent studies have linked these drugs to potentially dangerous side-effects, such as ketoacidosis, kidney damage and increased risk of bone fracture. Accordingly, a number of cases have been filed against drug makers alleging injuries suffered from taking Invokana. Those cases have been slated to be consolidated into a Multi-District Litigation (MDL), which centralizes pretrial activities for multiple cases to save time, court costs, and attorneyss fees.
In early 2017, results from two large clinical trials indicated that patients taking Invokana were roughly twice as likely to experience amputation injuries as patients on a placebo, causing the FDA to require a black box warning in July 2017:
WARNING: LOWER LIMB AMPUTATION. See full prescribing information for complete boxed warning. • In patients with type 2 diabetes who have established cardiovascular disease (CVD) or at risk for CVD, INVOKANA has been associated with lower limb amputations, most frequently of the toe and midfoot; some also involved the leg (5.1) • Before initiating, consider factors that may increase the risk of amputation. Monitor patients receiving INVOKANA for infections or ulcers of the lower limbs, and discontinue if these occur. READ MORE ABOUT THIS WARNING.
Are you impacted by the Invokana lawsuits? You may be entitled to compensation.
If you or a loved one has taken Invokana and believe you have suffered an injury, it is strongly recommended you speak with your physician. Injuries from Invokana use can allegedly include ketoacidosis. Ketoacidosis is a serious condition in which the body produces high levels of blood acids called ketones. Symptoms of ketoacidosis include nausea, vomiting, abdominal pain, tiredness, and trouble breathing. Ketoacidosis can lead to very serious permanent injuries. Injuries from Invokana use can also allegedly include kidney damage and increased risk of bone fracture. If you or a loved one has taken Invokana or another SGLT2 and believe you have suffered an injury, it is strongly recommended that you seek counsel experienced in the Invokana claims and injuries.
Stark & Stark attorneys are actively seeking Invokana settlements and filing Invokana lawsuits for those injured or killed from the potentially defective drug.
What is Invokana, and are there Invokana Lawsuits?
Invokana and other SGLT2 inhibitors reduce the amount of glucose being absorbed in the kidneys so that it is passed out in the urine, thereby reducing the amount of glucose in your blood. Other SGLT2 inhibitors include Invokamet (canagliflozin/metformin), Farxiga (dapagliflozin), Jardiance (empagliflozin), Glyxambi (empagliflozin/linagliptin), and Xigduo XR (dapagliflozin/metformin). These drugs are sold by various drug makers, including AstraZeneca, Johnson & Johnson, Eli Lilly and Boehringer Ingleheim.
In May and December of 2015, the FDA warned that taking SGLT2 inhibitors for diabetes may result in excessive acid in the blood. Additionally, according to studies, including a 2016 study published in the Journal of American Medical Association (JAMA Internal Medicine), SGLT2 inhibitors have been found to potentially increase the risk of kidney damage in patients who took the drugs. Currently, lawsuits have been filed against the makers of Invokana and other SGLT2 inhibitor manufacturers, claiming that the drugs cause acute interstitial nephritis, chronic kidney disease, end-stage renal disease, and acute kidney injuries. These lawsuits have been sought to be consolidated in an MDL in the United States District Court, District of New Jersey. The allegations in the Invokana MDL include claims that the Invokana and other SGLT2 manufacturers knew of the defect in their products, and resulting danger to the public, but failed to properly warn patients or their doctors.
Contact an Invokana Lawsuit Lawyer to Assess Your Claim.
The Invokana and SGLT2 attorneys at Stark & Stark are actively pursuing Invokana settlements and filing Invokana lawsuits against manufacturers on behalf of patients injured or killed from use of these potentially harmful drugs.
Stark & Stark is committed to holding drug and medical device manufacturers liable when their products improperly endanger the public. Our Invokana lawyers are experienced in mass torts MDL litigation cases and in negotiating with medical device and pharmaceutical settlement representatives.
If you or a member of your family has suffered an injury from Invokana or other SGLT2 use, you may be entitled to compensation under the MDL litigation process or via settlement.
Please contact Stark & Stark to speak with one of the Invokana and SGLT2 attorneys, free of charge, who can help assess any claims that you may have and to help you understand the Invokana settlement and lawsuit process.